Form 4: UNH Director Acquires Shares via Dividend Equivalents
Insider Transaction Report
UnitedHealth Group Director Charles D. Baker acquired 11 shares of common stock on December 16, 2025, through dividend equivalents on vested deferred stock units.
Summary
- Charles D. Baker, a Director of UnitedHealth Group Inc. (UNH), acquired 11 shares of common stock.
- The transaction occurred on December 16, 2025.
- These shares were acquired at a price of $0, representing dividend equivalents paid on vested deferred stock units.
- Following this transaction, Mr. Baker beneficially owns 1,527 shares of common stock directly.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 6
Explanation: The filing reports a routine, non-discretionary acquisition of a small number of shares by a director through dividend equivalents. While it indicates continued ownership and participation, it does not suggest significant new positive or negative developments for the company.
Positives
- A director increasing their stake, even through dividend reinvestment, can signal confidence in the company's long-term prospects.
- The transaction was executed under a Rule 10b5-1 plan, indicating a pre-arranged, non-discretionary acquisition.
Industry Context
This is a routine insider transaction disclosure for a director of a major healthcare company. Such filings provide transparency into executive and director stock ownership changes but typically do not reflect broader industry trends or competitive dynamics.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan Disclosure | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 12/16/2025 | This indicates a pre-arranged trading plan, enhancing transparency and reducing the perception of opportunistic insider trading. |
Stakeholder Impact
- Shareholders: Provides transparency regarding director ownership and a minor, routine increase in a director's stake, which can be seen as a positive signal of alignment.
Key Dates
| Date | Description |
|---|---|
| 12/16/2025 | Date of transaction where 11 shares of common stock were acquired. |
| 12/18/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdThis Form 4 filing details a routine, non-discretionary acquisition of a small number of shares by a director through dividend equivalents. It does not provide new material information that would warrant a change in investment recommendation. The transaction is part of a pre-arranged plan and does not signal a significant shift in company fundamentals or outlook.
Keywords
UnitedHealth Group, UNH, Insider transaction, Form 4, Charles D. Baker, Director, Stock acquisition, Dividend equivalents, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.